The veteran travel retail executive will be representing Team King Power Group ( Hong Kong) in supporting #KickCancerThon by ...

A new study suggests that the immune checkpoint inhibitor, durvalumab, may offer new treatment options for patients living ...

A former San Francisco firefighter and his family are pleading with San Francisco officials to intervene in what they ...

RVMD stays a Strong Buy as RAS inhibitor trials advance; phase 3 RASolute-302 is a key 2026 catalyst. Read the latest ...

The data illustrate that several patients remained on zenocutuzumab well beyond progression, including multiple patients who continued treatment for more than one- or two-years post-progression.

Researchers and health experts in India are raising the alarm that lung cancer, long linked to smoking, is increasingly ...

The new Indian Council of Medical Research (ICMR) study shows that lung cancer incidence will be the highest in the ...

India is likely to witness a sharp rise in lung cancer cases by 2030, with the North-East emerging as the most affected ...

India's lung cancer burden is projected to rise sharply by 2030, with the North-East emerging as the worst-affected region ...

The new artificial intelligence-based software and robot-assisted biopsy technology helps providers catch and treat lung cancer in its earliest stages.

Background: Human epidermal growth factor receptor 2 (HER2) gene amplification in lung adenocarcinoma is associated with aggressive tumor behavior and poor prognosis. Currently, there is no standard ...

In Brazil, the early detection of genetic alterations in lung cancer through liquid biopsies could be a valuable tool for ...